불임 검사 시장 : 제품, 구매 형태, 용도, 최종 사용자별 - 세계 예측(2025-2030년)

The Fertility Testing Market was valued at USD 352.00 million in 2023, expected to reach USD 382.90 million in 2024, and is projected to grow at a CAGR of 8.87%, to USD 638.16 million by 2030.

The fertility testing market encompasses a range of diagnostic products and services aimed at assessing, predicting, and improving reproductive health, especially important as fertility rates decline globally in many regions. The necessity for these tests arises from increasing infertility rates due to factors such as rising maternal age, lifestyle-induced conditions, and greater awareness and acceptance of fertility testing. Applications range from at-home ovulation and sperm tests to complex clinical procedures like hysteroscopy and sonohysterography. End-users include hospitals, fertility clinics, and homecare settings, with digital platforms expanding accessibility and user engagement. Key growth factors in this market include technological advancements in biomarkers and genetic testing, increasing enterprise collaborations, and the expanding scope of telemedicine. Moreover, the rise of personalized medicine and growing investment in research and development contribute significantly. Potential opportunities lie within developing innovative predictive algorithms and AI-driven diagnostic tools, which could facilitate early and precise fertility assessments. Companies are encouraged to focus on emerging markets where awareness and accessibility are rapidly growing. However, the market faces limitations, such as high procedural costs, privacy concerns, and socio-cultural taboos surrounding infertility and testing. Furthermore, challenging factors include regulatory hurdles and variability in test accuracy and reliability. Areas ripe for innovation include non-invasive testing methods, integration of fertility tracking with wearable technology, and the development of comprehensive digital health platforms that provide holistic reproductive health solutions. The fertility testing market is dynamic and subject to rapid changes influenced by both technological advancements and shifting socio-cultural attitudes toward fertility and family planning. Businesses aiming for growth should adopt a consumer-centric strategy, emphasizing affordability, privacy, and robust educational resources to overcome the barriers of stigma and misinformation, thereby maximizing market penetration and capturing burgeoning demand.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fertility Testing Market

The Fertility Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Declining fertility rates across the globe
  • Awareness about fertility testing
  • Introduction of advanced and easy-to-use fertility monitors with high accuracy
• Market Restraints
  • Lesser precision to confirm ovulation
• Market Opportunities
  • Combined test kit for testing of pregnancy and ovulation
  • Increase in R&D activities
• Market Challenges
  • Lesser precision of ovulation prediction kits

Porter's Five Forces: A Strategic Tool for Navigating the Fertility Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fertility Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fertility Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fertility Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fertility Testing Market

A detailed market share analysis in the Fertility Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fertility Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fertility Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fertility Testing Market

A strategic analysis of the Fertility Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fertility Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuQuik, Advacare Pharma, AvaWomen, Babystart, Church & Dwight Co., Inc, Fairhaven Health LLC, Geratherm Medical AG, Mira Care, Prestige Brands Holdings, Inc., Procter & Gamble, Quidel Corporation, Rite Aid Corporation, TaiDoc Technology Corporation, and UEBE Medical GmbH.

Market Segmentation & Coverage

This research report categorizes the Fertility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Fertility Monitoring Devices, Male Fertility Testing Products, and Ovulation Predictor Kits. The Fertility Monitoring Devices is further studied across Saliva-Based Monitor and Urine-Based Monitor.
• Based on Mode of Purchase, market is studied across Non-Prescription or OTC-Based, Online, and Prescription-Based.
• Based on Application, market is studied across Female Fertility Testing and Male Fertility Testing.
• Based on End-User, market is studied across Homecare Settings, Hospitals, and Specialty Clinics & Fertility Center.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Declining fertility rates across the globe
    • 5.1.1.2. Awareness about fertility testing
    • 5.1.1.3. Introduction of advanced and easy-to-use fertility monitors with high accuracy
  • 5.1.2. Restraints
    • 5.1.2.1. Lesser precision to confirm ovulation
  • 5.1.3. Opportunities
    • 5.1.3.1. Combined test kit for testing of pregnancy and ovulation
    • 5.1.3.2. Increase in R&D activities
  • 5.1.4. Challenges
    • 5.1.4.1. Lesser precision of ovulation prediction kits
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Fertility Testing Market, by Product

• 6.1. Introduction
• 6.2. Fertility Monitoring Devices
  • 6.2.1. Saliva-Based Monitor
  • 6.2.2. Urine-Based Monitor
• 6.3. Male Fertility Testing Products
• 6.4. Ovulation Predictor Kits

7. Fertility Testing Market, by Mode of Purchase

• 7.1. Introduction
• 7.2. Non-Prescription or OTC-Based
• 7.3. Online
• 7.4. Prescription-Based

8. Fertility Testing Market, by Application

• 8.1. Introduction
• 8.2. Female Fertility Testing
• 8.3. Male Fertility Testing

9. Fertility Testing Market, by End-User

• 9.1. Introduction
• 9.2. Homecare Settings
• 9.3. Hospitals
• 9.4. Specialty Clinics & Fertility Center

10. Americas Fertility Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Fertility Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Fertility Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AccuQuik
• 3. Advacare Pharma
• 4. AvaWomen
• 5. Babystart
• 6. Church & Dwight Co., Inc
• 7. Fairhaven Health LLC
• 8. Geratherm Medical AG
• 9. Mira Care
• 10. Prestige Brands Holdings, Inc.
• 11. Procter & Gamble
• 12. Quidel Corporation
• 13. Rite Aid Corporation
• 14. TaiDoc Technology Corporation
• 15. UEBE Medical GmbH